Navigation Links
Global Vision Recognized for Helping Pharmaceutical Companies Achieve Complete Artwork and Copy Accuracy in their Packaging Process
Date:10/22/2008

MONTREAL, Oct. 22 /PRNewswire/ -- Global Vision, the leader in automated proofreading solutions for the pharmaceutical industry announced today that 15 of the top 20 pharmaceutical companies have selected Global Vision to help them reduce the risk of textual and artwork errors from occurring in their packaging process. The integration of automated proofreading technology has resulted in a reduction of quality issues and costs, along with speeding up product launches.

Debi Schimpf, Associate Director at Wyeth comments "Global Vision has helped us implement better methods for detecting errors before they become costly. They're extremely knowledgeable when it comes to securing the artwork packaging workflow. Over the last 10 years of working with Global Vision, we have realized significant benefits and financial savings."

In the pharmaceutical manufacturing environment, there are thousands of packaging components being produced in a multitude of languages each year. Keeping track of the accuracy of these materials is a complex and challenging undertaking. Global Vision's technology is becoming a standard way for companies to ensure that their products reach the shelves without labeling errors.

"These companies are turning to us because we can offer them a safer and simpler way to work. Our customers need to feel confident in their approval and change control process. We give them peace of mind, along with the added benefits of decreased approval times and significant cost savings," says President Reuben Malz.

Global Vision is committed to providing solutions to ensure that all aspects of the packaging process are accurate. Global Vision has recently integrated Braille inspection capabilities into all its solutions in compliance with the recent EMEA regulations that require Braille on labels and cartons.

All systems meet EMEA and FDA 21 CFR Part 11 requirements.

About Global Vision

Global Vision provides automa
'/>"/>

SOURCE Global Vision, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Video: OneTouch(R) Teams With Online Diabetes Community to Launch Global Diabetes Handprint Project
2. ViroPharma Enhances Leadership to Support Global Growth and Expanding Business
3. China-Biotics, Inc. Approved to List on the Nasdaq Global Market
4. BIO Ventures for Global Health Receives $7 Million Grant from Gates Foundation to Engage Biotechnology in the Fight Against Neglected Diseases of the Developing World
5. Mentice Appoints Bjorn Larsson as Vice President of Global Marketing
6. International Diabetes Federation Calls for Global Action to Keep All Children With Diabetes Alive
7. The Plasmodium vivax genome provides new routes and challenges in the global fight against malaria
8. Neptune Technologies and Marine Life Sciences enter worldwide distribution alliance with Weider Global Nutrition
9. Kendle to Present at the UBS Global Life Sciences Conference
10. Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference
11. Boston Scientific to Participate in UBS Global Life Sciences Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...NA, Austria, November 6 EUCODIS Bi...acturing, and marketing enzymes for the,chemical i... research,agreement with Bio Sidus, the leading bi... The agreement gives EUCODIS Bioscience exclusiv... to Bio Sidus, proprietary collection of,psychroph...
(Date:11/6/2009)... The agenda for Arrowhead’s 2010 ...ch is set to take place on February 22-24, 2010 in...ay conference we will highlight key issues in form...hare their experiences. , ...genda for Arrowhead’s 2010 Personalized Med...
(Date:11/5/2009)...O, Nov. 5 Imagenetix, In...t William Spencer, President and CEO of Imagenetix...d annual LD MICRO Conference on Thursday, December...geles. ,, About LD MICRO ,, LD MICRO is a by...inding undervalued companies in the micro-cap spac...
(Date:11/5/2009)...E, Calif., Nov. 5 Cephei...ives will be speaking at the following investor co...a webcast. , , Credit Suisse Healt...rsday, 12 November, 2009 at 10 a.m. Mountain Time,..., London, England, Tuesday, 1 Dece...
Breaking Biology Technology:EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2Cepheid to Webcast Upcoming Financial Presentations 2
... PAREXEL International,Corporation (Nasdaq: PRXL ...anization, today announced the successful completi...tional Clinical Research Co., Ltd. ("APEX") in,a s...uisition and other,factors discussed herein, the C...uidance for the first quarter of Fiscal Year 2008 ...
... Sept. 26 InterMune, Inc.,(Nasdaq: ITMN ) today ...025,000 shares of common stock at a price to the p...s of common stock, representing the exercise,by th...nal shares in the,offering. The net proceeds to th...million, after payment of underwriting discounts a...
...., Sept. 26 Corium International,Inc., a privatel...nounced,that it has completed a $25.1 million Seri...res. Quantum Technology Partners, Aphelion Capital... round. In connection with,the financing, StrataGe...Ventures portfolio company focused on needle-free ...
Other Biology Technology:PAREXEL International Updates Financial Guidance in Conjunction with the Acquisition of APEX International Clinical Research Co., Ltd. and Other Factors 2PAREXEL International Updates Financial Guidance in Conjunction with the Acquisition of APEX International Clinical Research Co., Ltd. and Other Factors 3PAREXEL International Updates Financial Guidance in Conjunction with the Acquisition of APEX International Clinical Research Co., Ltd. and Other Factors 4InterMune Announces Closing of Public Offering of Common Stock 2Corium International, Inc., Announces $40 Million Financing led by Essex Woodlands Health Ventures 2Corium International, Inc., Announces $40 Million Financing led by Essex Woodlands Health Ventures 3Corium International, Inc., Announces $40 Million Financing led by Essex Woodlands Health Ventures 4
(Date:11/6/2009)... Center and the Chinese Academy of Sciences (CAS) ...on Taste and Smell Research. Organized by Monell i...the first international meeting on taste and smell...utive Officer, American Association for the Advanc...e magazine, will open the meeting with a plenary a...
(Date:11/5/2009)...ty have developed synthetic molecules capable of e...-infected cells, as well as to prostate cancer cel...al of the American Chemical Society , could lead t... , The molecules called "antibody-recruiting m...iting molecule targeting prostate cancer" (ARM-P) ...
(Date:11/4/2009)...ant to officially endorse green tea as a cancer pr...its protective effects, including results of a new...a journal of the American Association for Cancer R...cer. , Vassiliki Papadimitrakopoulo, M.D., prof...ad and Neck Medical Oncology at the University of ...
Breaking Biology News(10 mins):Monell Center joins with CAS to host Beijing meeting on taste and smell research 2New synthetic molecules trigger immune response to HIV and prostate cancer 2Does green tea prevent cancer? Evidence continues to brew, but questions remain 2UNC scientists garner new NIH awards for high risk transformative research 10076 1UNC scientists garner new NIH awards for high risk transformative research 10076 2UNC scientists garner new NIH awards for high risk transformative research 10076 3UNC scientists garner new NIH awards for high risk transformative research 10076 4Thomson Reuters Predicts Nobel Laureates 14245 1Thomson Reuters Predicts Nobel Laureates 14245 2Thomson Reuters Predicts Nobel Laureates 14245 3Thomson Reuters Predicts Nobel Laureates 14245 4Thomson Reuters Predicts Nobel Laureates 14245 5Thomson Reuters Predicts Nobel Laureates 14245 6RetireSafe to Senate 3A Stop Proposed Rationing of High Quality Hospital Care Medicare Needs More Physician Hospitals 58219 1RetireSafe to Senate 3A Stop Proposed Rationing of High Quality Hospital Care Medicare Needs More Physician Hospitals 58219 2
.... A hypertension medication called olmesartan med...the arteries that occurs in patients with high blo... Ferrario, M.D., one of the study,s lead investiga... Research Center at Wake Forest University Baptist... the growing evidence for the role of angiotensin ...
...he Smithsonian,s National Zoo have performed the f...s horse ( E. ferus przewalskii ; E. caballus prze...-VAL-skeez. Przewalksi,s horses are a horse specie...xtinct in the wild in 1970. Currently, there are a...oological institutions throughout the world and in...
...nce and technology policymaking capacity of the Wh...ent can better address key issues facing the natio...rity, and the ability of the United States to comp...primary recommendations are that: , The next P...ader to be Assistant for Science and Technology Po...
Other Biology News:Hypertension treatment effective in reversing vascular damage 2First successful reverse vasectomy on endangered species performed at the National Zoo 2First successful reverse vasectomy on endangered species performed at the National Zoo 3White House science office needs upgrade 2White House science office needs upgrade 3
Human SLPI ELISA Kit from R&D Systems
Rabbit Anti-Human OLFM1 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
GELase 50X Reaction Buffer from EPICENTRE Biotechnologies
Axl, phospho ELISA development Kit, DuoSet IC Economy Pack from R&D Systems
Biology Products: